MedPath

Eerulli ennai for childhood asthma

Phase 2
Conditions
Health Condition 1: null- Children of the age group 1 to 3 years with symptoms of:WheezingDyspnoeaIntermittent feverIndrawing of respiratory musclesInsomnia,Hiccough,Refuse the feeding
Registration Number
CTRI/2017/04/008324
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Children of the age group 1 to 3 years with symptoms of:

Wheezing,

Dyspnoea

Intermittent fever

Indrawing of respiratory muscles

Insomnia,

Hiccough,

Refuse the feeding

Willing to sign the informed consent form

Exclusion Criteria

Jaundice,

Long term fever,

Active primary complex

Congenital heart diseases

Any other serious illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in episodes of wheezing is assessed by modified CAS asthma score.Timepoint: 5 days
Secondary Outcome Measures
NameTimeMethod
clinical efficacy of the trail drug and its side effects if anyTimepoint: 15 days
© Copyright 2025. All Rights Reserved by MedPath